The serum levels of Galectin-1(40.57± 22.2 ng/ml) in patients with newly diagnosed ovarian tumours (n=84) were significantly higher than the levels (9.19± 4.61ng/ml) (p<0.0001) in healthy controls (n=20) (Fig. 2a). This evidence concerns the gene LGALS1 and ovarian neoplasm.